Mindi Price
Nurse Practitioner · Tulsa, OKNPI 1962800268
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (48.6%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Axsome Therapeutics, Inc. accounts for 63.0% of it on its own, with 17 other manufacturers making up the rest. 2025 is the largest year on record at $8,827, more than ten times the $42 reported in 2021. Among nurse practitioner clinicians in OK with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 121 payments — averaging $91.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Axsome Therapeutics, Inc.$7K
- Inspire Medical Systems, Inc.$2K
- Jazz Pharmaceuticals Inc.$2K
- Harmony Biosciences LLC$286
- Avadel CNS Pharmaceuticals, LLC$128
- Idorsia Pharmaceuticals US Inc$49
- plus $239 from 12 others
What the payments were for
- Speaking & faculty fees$5,37549%
- Travel & lodging$1,34412%
- Food & beverage$4,03136%
- Education$3003%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Axsome Therapeutics, Inc. | 15 | $6,966 |
| Inspire Medical Systems, Inc. | 31 | $1,879 |
| Jazz Pharmaceuticals Inc. | 45 | $1,503 |
| Harmony Biosciences LLC | 12 | $286 |
| Avadel CNS Pharmaceuticals, LLC | 3 | $128 |
| Idorsia Pharmaceuticals US Inc | 3 | $49 |
| Alnylam Pharmaceuticals Inc. | 1 | $29 |
| 3b Medical, Inc. | 1 | $28 |
| Boston Scientific | 1 | $26 |
| Abbott | 1 | $25 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $23 |
| Esperion Therapeutics, Inc. | 1 | $18 |
| Actelion Pharmaceuticals US, Inc. | 1 | $17 |
| Bayer | 1 | $16 |
| Lilly USA, LLC | 1 | $15 |
| Eisai Inc. | 1 | $15 |
| Lexicon Pharmaceuticals, Inc. | 1 | $14 |
| Boehringer Ingelheim | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SUNOSI$6,624
- Inspire$1,283
- XYWAV$244
- Inspire Upper Airway Stimulation System$135
How this compares
$11,050 in reported general payments places this provider in the 95th percentile of 824 nurse practitioner providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Armodafinil | 18 | $1,156 |
| Modafinil | 11 | $513 |
| Quetiapine Fumarate | 56 | $365 |
| Zolpidem Tartrate | 37 | $178 |
| Ropinirole Hcl | 31 | $153 |
| Trazodone Hcl | 38 | $145 |
| Clonazepam | 21 | $74 |
| Gabapentin | 17 | $39 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Tulsa
- Jenny GuthrieTulsa$106K
- Stacy NewberryTulsa$28K
- Amanda SmallTulsa$14K
- Huong HuynhTulsa$10K
- Jonathan BouldinTulsa$10K
- Michelle LoeberTulsa$10K
- Erin WilliamsonTulsa$9K
- Andrea CarpenterTulsa$7K
- Charles SpradlinTulsa$7K
- Leslie BurtonTulsa$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.